ALL and certain types of non-lymphoma cancer in adults are treated with CAR T Cell Therapy
CAR T Cell Therapy Market |
CAR T-cell treatment stands for chimeric antigen receptor
T-cell therapy. T-cell therapy is a sort of treatment in which a patient's T
cells (a type of immune cell) are genetically modified to bind to cancer cells
and kill them. Blood runs through a tube from a vein in the patient's arm to an
apheresis machine (not shown), which filters out the white blood cells,
including T cells, and returns the remainder of the blood to the patient. Then,
in the lab, the gene for a particular receptor known as a chimeric antigen
receptor (CAR) is injected into T cells. Thousands of CAR T cells are generated
in the lab before being infused into the patient. The CAR T cells can connect
to and kill cancer cells by binding to an antigen on their surface.
The global Car
T Cell therapy market is estimated to be valued at US$ 1,085.0 million
in 2021 and is expected to exhibit a CAGR of 24.5% during the forecast period
(2021-2028).
CAR T-cell therapy, or chimeric antigen receptor T-cell
therapy, is a cancer treatment that employs cells from your own immune system.
Doctors take a type of white blood cell from your body and genetically alter it
in a lab to help them discover your cancer more quickly. Then your body is
re-inoculated with millions of these target-seeking cells.
Because the treatment is so new, doctors aren't sure how
effectively it works or how long it will persist. The cost is also fairly
significant, and some insurance companies have yet to come up with a way to
cover it. Before deciding if the therapy is right for you, talk to your doctor
about the benefits and drawbacks. CAR T is licenced to treat ALL in children
and young adults, as well as specific kinds of adult non-lymphoma. Hodgkin's In
clinical trials, doctors are evaluating it for various types of blood cancer.
The primary line of treatment for these disorders is
chemotherapy (chemo) and stem cell transplants. However, if they don't work
after two tries or if the cancer returns after treatment, CAR T may be a
choice. It could be the last chance for some people to get a cure.
Comments
Post a Comment